Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abemaciclib in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, and in Children With Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors

NCT02644460 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02644460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abemaciclib in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, and in Children With Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2016
Completion date
October 10, 2023
Enrollment
53 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, diffuse intrinsic pontine glioma, ewing sarcoma, recurrent, refractory, neuroblastoma, recurrent, refractory, osteosarcoma, recurrent, refractory, rhabdoid tumor, recurrent, refractory, rhabdomyosarcoma, recurrent, refractory, solid tumor, recurrent